ReviewFrontiers in medicine2026
Perioperative inflammation in gynecologic oncology: nursing strategies for enhanced recovery and complication prevention.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major gynecologic oncology surgery produces an acute inflammatory and neuroendocrine stress response superimposed on cancer-associated inflammation, frailty, malnutrition, anemia, and treatment-related physiologic vulnerability. Although this response is necessary for tissue repair, excessive or poorly resolved activation can contribute to pain, postoperative nausea and vomiting, ileus, insulin resistance, endothelial dysfunction, infection, venous thromboembolism, functional decline, and delayed return to oncologic treatment. Enhanced recovery after surgery (ERAS) pathways reduce avoidable stressors through coordinated, multimodal care, but their effectiveness depends on reliable implementation across the entire perioperative continuum. Nurses are positioned at the interfaces where risk is identified, pathway elements are delivered, trajectory deviations are recognized, and escalation occurs. This Mini Review synthesizes the inflammatory biology most relevant to gynecologic oncology nursing and translates it into practical strategies for preoperative screening and education, protocol verification, multimodal symptom control, early feeding and mobilization, infection and thromboembolism prevention, structured postoperative surveillance, and digitally supported follow-up. C-reactive protein and other inflammatory indices may complement assessment in selected pathways, but they are nonspecific and should not replace clinical evaluation or procedure-specific escalation criteria. The central proposition is that nursing care can be made inflammation-sensitive without becoming biomarker-driven: modifiable inflammatory inputs should be reduced, physiologic reserve should be preserved, self-reinforcing complication loops should be interrupted, and recovery trajectories should be monitored consistently. Future studies should test nurse-coordinated bundles using implementation, patient-reported, functional, and oncologic-process outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.